High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$19.7M
$19,704,706
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| HALO |
HALOZYME THERAPEUTICS, INC.
|
COO
Other
|
2026-03-10 | $51,806 | M | Form 4 |
|
HALO
S
HALOZYME THERAPEUTICS, INC.
Caudill Cortney
• COO
Discretionary SellΔOwn -55.7%
2026-03-10
$599,087
|
||||||
| HALO |
HALOZYME THERAPEUTICS, INC.
|
COO
Discretionary SellΔOwn -55.7%
|
2026-03-10 | $599,087 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
COO
Other
|
2026-03-09 | $670,200 | M | Form 4 |
|
HALO
S
HALOZYME THERAPEUTICS, INC.
Caudill Cortney
• COO
Discretionary SellΔOwn -52.1%
2026-03-09
$1,212,743Large
|
||||||
| HALO |
HALOZYME THERAPEUTICS, INC.
|
COO
Discretionary SellΔOwn -52.1%
|
2026-03-09 | $1,212,743Large | S | Form 4 |
|
HALO
S
HALOZYME THERAPEUTICS, INC.
Caudill Cortney
• COO
Discretionary SellΔOwn -12.8%
2026-03-09
$143,329
|
||||||
| HALO |
HALOZYME THERAPEUTICS, INC.
|
COO
Discretionary SellΔOwn -12.8%
|
2026-03-09 | $143,329 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2026-03-04 | $120,700 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-03-04 | $189,494 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-03-04 | $512,620 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-03-03 | $928,167 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2026-03-03 | $241,400 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-03-03 | $451,982 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-03-02 | $40,726 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2026-03-02 | $241,400 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-03-02 | $1,069,460Large | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-03-02 | $283,708 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-02-05 | $365,000 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-02-05 | $421,366 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2026-02-05 | $120,700 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2026-02-04 | $241,400 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-02-04 | $783,154 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-02-04 | $761,666 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-02-03 | $733,543 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-02-03 | $597,758 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2026-02-03 | $241,400 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-02-03 | $191,016 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-12-01 | $712,936 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
Director
10b5-1 Sell
|
2025-12-01 | $59,356 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2025-12-01 | $134,375 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-12-01 | $18,688 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-12-01 | $35,181 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-12-01 | $375,120 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $35,690 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2025-11-12 | $162,200 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $893,033 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $482,268 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-11-11 | $275,180 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2025-11-11 | $162,200 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-11-11 | $305,514 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-11-11 | $801,906 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2025-11-10 | $162,200 | M | Form 4 |
|
HALO
S
HALOZYME THERAPEUTICS, INC.
Connaughton Bernadette
• Director
10b5-1 Sell
2025-11-10
$136,960
|
||||||
| HALO |
HALOZYME THERAPEUTICS, INC.
|
Director
10b5-1 Sell
|
2025-11-10 | $136,960 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-11-10 | $1,367,409Large | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-11-10 | $6,930 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
COO
Equity Compensation
|
2025-11-01 | $0 | M | Form 4 |
|
HALO
S
HALOZYME THERAPEUTICS, INC.
Caudill Cortney
• COO
Sell to CoverΔOwn -25.1%
2025-11-01
$277,905
|
||||||
| HALO |
HALOZYME THERAPEUTICS, INC.
|
COO
Sell to CoverΔOwn -25.1%
|
2025-11-01 | $277,905 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-10-03 | $51,891 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-10-03 | $191,065 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-10-03 | $162,983 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-10-03 | $974,699 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2025-10-03 | $162,200 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-10-02 | $465,359 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-10-02 | $727,036 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-10-02 | $172,956 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-10-02 | $51,265 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-10-02 | $7,467 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2025-10-02 | $162,200 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2025-10-01 | $162,200 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
Director
10b5-1 Sell
|
2025-10-01 | $37,852 | S | Form 4 |
|
HALO
S
HALOZYME THERAPEUTICS, INC.
Connaughton Bernadette
• Director
10b5-1 Sell
2025-10-01
$112,629
|
||||||
| HALO |
HALOZYME THERAPEUTICS, INC.
|
Director
10b5-1 Sell
|
2025-10-01 | $112,629 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-10-01 | $879,151 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2025-10-01 | $627,873 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CFO
10b5-1 Sell
|
2025-09-22 | $24,701 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CFO
10b5-1 Sell
|
2025-09-22 | $148,883 | S | Form 4 |